VIC Technology Venture Development

Nob Hill Therapeutics, Inc. is a Delaware Corporation founded in 2016 and based in Fayetteville, Arkansas. The company specializes in developing and marketing DryNeb, a pioneering dry powder nebulizer designed to treat severe respiratory diseases. This innovative device distinguishes itself from traditional aerosol mist nebulizers by being compact, handheld, and portable, providing a more user-friendly experience. The DryNeb nebulizer utilizes a unique mechanism that disperses medication through mechanical collisions within a dispersion chamber, ensuring consistent delivery independent of the patient's inhalation force. This technology allows for effective pulmonary drug delivery, which is increasingly important for both local and systemic treatments due to its high bioavailability and rapid action. Nob Hill Therapeutics has exclusively licensed this technology from the University of New Mexico, positioning itself to address significant market opportunities in pulmonary drug delivery.

Neurexis Therapeutics specializes in developing innovative treatments for conditions such as stroke and cardiac arrest. The company focuses on providing therapeutic peptides that aim to significantly reduce brain damage resulting from strokes. Their proprietary platform features an optimized peptide designed with two functional domains that facilitate crossing the blood-brain barrier. This advancement offers a neuroprotective option for stroke patients, helping to lessen both immediate brain damage and long-term health consequences. Additionally, Neurexis Therapeutics addresses various medical conditions, including cerebral ischemia, sickle cell anemia, congenital heart defects, vascular surgery, and pre-existing coronary disease.

Solenic Medical, a medical device company that develops a non-invasive treatment for infected metallic implants in the body. The company leverages the properties of alternating magnetic fields (AMF) generated from external coils to eradicate biofilm on the surface of medical implants. This non-invasive treatment addresses a major complication of various surgeries, such as knee and hip replacements, as well as in trauma-related implants such as plates and rods. Its AMF technology has the potential to completely replace the very expensive and risky two-step revision surgical procedure, which is the current standard of care for chronic infections on medical implants. Rajiv Chopra and David Greenberg founded it in College Station, Texas in 2019.

Filtravate is a membrane technology company focused on the development of ultrafiltration membranes primarily for the bioprocessing and biopharmaceutical sectors. The company's membranes are distinguished by their controlled and tunable pore sizes, uniform pore distribution, and functionalized surfaces. These features, derived from patent-pending technology licensed from New Mexico State University, are designed to enhance performance by providing significant anti-fouling properties and improved flux characteristics, making them suitable for a variety of applications within the pharmaceutical industry.

Solenic Medical, a medical device company that develops a non-invasive treatment for infected metallic implants in the body. The company leverages the properties of alternating magnetic fields (AMF) generated from external coils to eradicate biofilm on the surface of medical implants. This non-invasive treatment addresses a major complication of various surgeries, such as knee and hip replacements, as well as in trauma-related implants such as plates and rods. Its AMF technology has the potential to completely replace the very expensive and risky two-step revision surgical procedure, which is the current standard of care for chronic infections on medical implants. Rajiv Chopra and David Greenberg founded it in College Station, Texas in 2019.